Eurofins Viracor Establishes Lenexa, Kansas, Laboratory Complex
10/07/2022
The new 110,000-square-foot-facility is part of the company’s continued investment in building capacity and capabilities to meet growing customer demand in biopharma and clinical diagnostic testing services, according to company officials. The location will allow for expanded molecular/genomic, next generation sequencing, immunoassay, cell-based, LCMS, and other bioanalytical testing services.
"I'm proud that an innovative company like Eurofins Viracor has chosen to call Kansas home," said Governor Laura Kelly. "Beyond providing 235 more Kansans with high-quality jobs, Eurofins Viracor will continue its crucial work to keep our nation safe and healthy."
Viracor Eurofins Laboratories is a diagnostic laboratory specializing in infectious disease, immunology and allergy testing for immunocompromised and critical patients.
"Governor Kelly's Kansas Framework for Growth specifically targets recruiting additional company headquarters and enhancing our state's bioscience sector," Lieutenant Governor and Secretary of Commerce David Toland noted. "Eurofins Viracor is the type of visionary company we want to attract to Kansas."
The Eurofins Viracor company headquarters, all laboratory testing equipment, and personnel have been moved to the new facility in Lenexa.
Project Announcements
SencorpWhite Plans Hamilton, Ohio, Headquarters-Manufacturing Operations
12/29/2025
Kraken Technologies Limited Plans New York City Headquarters Operations
12/29/2025
Lupin Expands Coral Springs, Florida, Operations
12/29/2025
KPPC Advanced Chemicals Expands Casa Grande, Arizona, Operations
12/29/2025
Volvo Group Plans Tacoma, Washington, Distribution Operations
12/29/2025
Alnylam Pharmaceuticals Expands Norton, Massachusetts, Operations
12/29/2025
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Rethinking Local Governments Through Consolidation and Choice
Q3 2025
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Lead with Facts, Land the Deal
Q3 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025
-
America’s Aerospace Reboot
Q3 2025